Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing
Basel, Switzerland – Jan. 5, 2017 – Therachon AG, a biotechnology company focused on rare genetic diseases, today announced it has appointed Luca Santarelli, M.D., as Chief Executive Officer and Director,…